Journey Medical Corporation/ US48115J1097 /
2024-05-08 10:00:00 PM | Chg. +0.1300 | Volume | Bid10:09:46 AM | Ask10:09:46 AM | High | Low |
---|---|---|---|---|---|---|
3.5700USD | +3.78% | 32,939 Turnover: 91,938.8376 |
1.4300Bid Size: 200 | 5.7100Ask Size: 200 | 3.7000 | 3.4200 |
GlobeNewswire
05-07
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
GlobeNewswire
04-25
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
GlobeNewswire
03-21
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire
03-18
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the...
GlobeNewswire
03-15
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
GlobeNewswire
03-11
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the...
GlobeNewswire
01-05
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
GlobeNewswire
01-02
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
GlobeNewswire
2023-12-06
Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-...
GlobeNewswire
2023-11-14
Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire
2023-11-07
Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highli...
GlobeNewswire
2023-10-31
Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023
GlobeNewswire
2023-10-20
Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydroch...
GlobeNewswire
2023-09-06
Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbr...
GlobeNewswire
2022-03-28
Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights
GlobeNewswire
2022-03-23
Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
GlobeNewswire
2022-03-18
Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update ...
GlobeNewswire
2022-03-17
Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-2...